vs
AMERICAN AXLE & MANUFACTURING HOLDINGS INC（AXL）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是AMERICAN AXLE & MANUFACTURING HOLDINGS INC的1.1倍（$1.5B vs $1.4B），Steris净利率更高（12.9% vs -5.4%，领先18.3%），Steris同比增速更快（9.2% vs 0.2%），Steris自由现金流更多（$199.5M vs $54.7M），过去两年Steris的营收复合增速更高（15.8% vs -7.2%）
美国车桥制造控股有限公司总部位于密歇根州底特律，是一家美国汽车传动轴与动力传动系统零部件及系统制造商，在汽车传动领域拥有成熟的技术与产能，为全球多家车企供应相关核心配件。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
AXL vs STE — 直观对比
营收规模更大
STE
是对方的1.1倍
$1.4B
营收增速更快
STE
高出8.9%
0.2%
净利率更高
STE
高出18.3%
-5.4%
自由现金流更多
STE
多$144.8M
$54.7M
两年增速更快
STE
近两年复合增速
-7.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.5B |
| 净利润 | $-75.3M | $192.9M |
| 毛利率 | 10.2% | 43.8% |
| 营业利润率 | -2.4% | 18.3% |
| 净利率 | -5.4% | 12.9% |
| 营收同比 | 0.2% | 9.2% |
| 净利润同比 | -449.6% | 11.2% |
| 每股收益（稀释后） | $-0.62 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXLSTE
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.4B | $1.5B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.6B | $1.3B | ||
| Q1 24 | $1.6B | $1.1B |
净利润AXLSTE
| Q4 25 | $-75.3M | $192.9M | ||
| Q3 25 | $9.2M | $191.9M | ||
| Q2 25 | $39.3M | $177.4M | ||
| Q1 25 | $7.1M | $145.7M | ||
| Q4 24 | $-13.7M | $173.5M | ||
| Q3 24 | $10.0M | $150.0M | ||
| Q2 24 | $18.2M | $145.4M | ||
| Q1 24 | $20.5M | $-1.4M |
毛利率AXLSTE
| Q4 25 | 10.2% | 43.8% | ||
| Q3 25 | 12.6% | 44.2% | ||
| Q2 25 | 13.1% | 45.1% | ||
| Q1 25 | 12.3% | 43.3% | ||
| Q4 24 | 11.2% | 44.5% | ||
| Q3 24 | 11.4% | 43.6% | ||
| Q2 24 | 13.3% | 44.7% | ||
| Q1 24 | 12.4% | 40.2% |
营业利润率AXLSTE
| Q4 25 | -2.4% | 18.3% | ||
| Q3 25 | 3.2% | 18.2% | ||
| Q2 25 | 3.6% | 17.7% | ||
| Q1 25 | 3.0% | 14.6% | ||
| Q4 24 | 2.6% | 17.9% | ||
| Q3 24 | 2.8% | 16.5% | ||
| Q2 24 | 5.3% | 14.5% | ||
| Q1 24 | 4.8% | 22.0% |
净利率AXLSTE
| Q4 25 | -5.4% | 12.9% | ||
| Q3 25 | 0.6% | 13.1% | ||
| Q2 25 | 2.6% | 12.8% | ||
| Q1 25 | 0.5% | 9.8% | ||
| Q4 24 | -1.0% | 12.7% | ||
| Q3 24 | 0.7% | 11.3% | ||
| Q2 24 | 1.1% | 11.4% | ||
| Q1 24 | 1.3% | -0.1% |
每股收益（稀释后）AXLSTE
| Q4 25 | $-0.62 | $1.96 | ||
| Q3 25 | $0.07 | $1.94 | ||
| Q2 25 | $0.32 | $1.79 | ||
| Q1 25 | $0.06 | $1.48 | ||
| Q4 24 | $-0.11 | $1.75 | ||
| Q3 24 | $0.08 | $1.51 | ||
| Q2 24 | $0.15 | $1.46 | ||
| Q1 24 | $0.17 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $708.9M | $423.7M |
| 总债务越低越好 | $4.0B | $1.9B |
| 股东权益账面价值 | $640.0M | $7.2B |
| 总资产 | $6.7B | $10.6B |
| 负债/权益比越低杠杆越低 | 6.31× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资AXLSTE
| Q4 25 | $708.9M | $423.7M | ||
| Q3 25 | $714.1M | $319.2M | ||
| Q2 25 | $586.5M | $279.7M | ||
| Q1 25 | $549.2M | $171.7M | ||
| Q4 24 | $552.9M | $155.2M | ||
| Q3 24 | $542.5M | $172.2M | ||
| Q2 24 | $519.9M | $198.3M | ||
| Q1 24 | $469.8M | $207.0M |
总债务AXLSTE
| Q4 25 | $4.0B | $1.9B | ||
| Q3 25 | $2.6B | $1.9B | ||
| Q2 25 | $2.6B | $1.9B | ||
| Q1 25 | $2.6B | $1.9B | ||
| Q4 24 | $2.6B | $2.0B | ||
| Q3 24 | $2.6B | $2.2B | ||
| Q2 24 | $2.7B | $2.2B | ||
| Q1 24 | $2.7B | $3.1B |
股东权益AXLSTE
| Q4 25 | $640.0M | $7.2B | ||
| Q3 25 | $718.4M | $7.0B | ||
| Q2 25 | $673.0M | $7.0B | ||
| Q1 25 | $596.3M | $6.6B | ||
| Q4 24 | $562.8M | $6.4B | ||
| Q3 24 | $616.3M | $6.6B | ||
| Q2 24 | $609.6M | $6.4B | ||
| Q1 24 | $621.4M | $6.3B |
总资产AXLSTE
| Q4 25 | $6.7B | $10.6B | ||
| Q3 25 | $5.3B | $10.4B | ||
| Q2 25 | $5.3B | $10.4B | ||
| Q1 25 | $5.1B | $10.1B | ||
| Q4 24 | $5.1B | $10.0B | ||
| Q3 24 | $5.3B | $10.2B | ||
| Q2 24 | $5.3B | $10.1B | ||
| Q1 24 | $5.4B | $11.1B |
负债/权益比AXLSTE
| Q4 25 | 6.31× | 0.27× | ||
| Q3 25 | 3.61× | 0.27× | ||
| Q2 25 | 3.86× | 0.27× | ||
| Q1 25 | 4.38× | 0.29× | ||
| Q4 24 | 4.58× | 0.32× | ||
| Q3 24 | 4.28× | 0.33× | ||
| Q2 24 | 4.42× | 0.35× | ||
| Q1 24 | 4.40× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $120.5M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $54.7M | $199.5M |
| 自由现金流率自由现金流/营收 | 4.0% | 13.3% |
| 资本支出强度资本支出/营收 | 4.8% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | $155.1M | $917.1M |
8季度趋势，按日历期对齐
经营现金流AXLSTE
| Q4 25 | $120.5M | $298.2M | ||
| Q3 25 | $143.3M | $287.8M | ||
| Q2 25 | $91.9M | $420.0M | ||
| Q1 25 | $55.9M | $260.8M | ||
| Q4 24 | $151.2M | $332.8M | ||
| Q3 24 | $143.6M | $250.7M | ||
| Q2 24 | $142.8M | $303.7M | ||
| Q1 24 | $17.8M | $254.8M |
自由现金流AXLSTE
| Q4 25 | $54.7M | $199.5M | ||
| Q3 25 | $79.2M | $201.3M | ||
| Q2 25 | $34.6M | $326.4M | ||
| Q1 25 | $-13.4M | $189.9M | ||
| Q4 24 | $73.2M | $243.6M | ||
| Q3 24 | $70.4M | $148.8M | ||
| Q2 24 | $94.0M | $195.7M | ||
| Q1 24 | $-30.2M | $163.3M |
自由现金流率AXLSTE
| Q4 25 | 4.0% | 13.3% | ||
| Q3 25 | 5.3% | 13.8% | ||
| Q2 25 | 2.3% | 23.5% | ||
| Q1 25 | -0.9% | 12.8% | ||
| Q4 24 | 5.3% | 17.8% | ||
| Q3 24 | 4.7% | 11.2% | ||
| Q2 24 | 5.8% | 15.3% | ||
| Q1 24 | -1.9% | 14.6% |
资本支出强度AXLSTE
| Q4 25 | 4.8% | 6.6% | ||
| Q3 25 | 4.3% | 5.9% | ||
| Q2 25 | 3.7% | 6.7% | ||
| Q1 25 | 4.9% | 4.8% | ||
| Q4 24 | 5.6% | 6.5% | ||
| Q3 24 | 4.9% | 7.7% | ||
| Q2 24 | 3.0% | 8.4% | ||
| Q1 24 | 3.0% | 8.2% |
现金转化率AXLSTE
| Q4 25 | — | 1.55× | ||
| Q3 25 | 15.58× | 1.50× | ||
| Q2 25 | 2.34× | 2.37× | ||
| Q1 25 | 7.87× | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | 14.36× | 1.67× | ||
| Q2 24 | 7.85× | 2.09× | ||
| Q1 24 | 0.87× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
